Tocilizumab for the treatment of retroperitoneal fibrosis
Phase 2
- Conditions
- retroperitoneal fibrosis
- Registration Number
- ACTRN12618000922279
- Lead Sponsor
- Azienda Ospedaliero Universitaria di Parma
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 18
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method